FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)

PHASE3CompletedINTERVENTIONAL
Enrollment

349

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

April 30, 2011

Study Completion Date

April 30, 2011

Conditions
Pulmonary Hypertension
Interventions
DRUG

Oral treprostinil (UT-15C) Sustained Release Tablets

Sustained release oral tablet, twice daily

OTHER

Placebo

Placebo oral tablet twice daily

Trial Locations (77)

Unknown

University of Alabama-Birmingham, Birmingham

Arizona Pulmonary Specialist, Phoenix

Mayo Clinic Arizona, Phoenix

University of California, San Francisco-Fresno, Fresno

West Los Angeles VA Healthcare Center, Los Angeles

UC Davis Medical Center, Sacramento

Harbor-UCLA Medical Center, Torrance

University of Colorado Health Science Center, Aurora

University of Florida - Shands Hospital, Jacksonville

Cleveland Clinic Florida, Weston

Emory University Hospital, Atlanta

University of Chicago Hospitals, Chicago

University of Iowa Hospital and Clinics, Iowa City

Kentuckiana Pulmonary Associates, Louisville

Alexandria Cardiology Clinic, Alexandria

Maine Medical Center, Portland

University of Maryland School of Medicine, Baltimore

Brigham and Women's Hospital, Boston

Tufts Medical Center, Boston

University of Michigan, Ann Arbor

Mayo Clinic, Rochester

Washington University Hospital, St Louis

Nebraska Medical Center, Omaha

Newark Beth Israel Medical Center, Newark

Winthrop University Hospital, Mineola

Columbia Presbyterian Medical Center, New York

Mary M Parkes Center for Asthma, Allergy and Pulmonary Care - University of Rochester, Rochester

The Lindner Center, Cincinnati

University of Cincinnati, Cincinnati

The Cleveland Clinic Foundation, Cleveland

University Hospitals of Cleveland, Cleveland

Ohio State University, Columbus

Legacy Clinic Northwest, Portland

Oregon Health and Science University, Portland

Allegheny General Hospital, Pittsburgh

University of Pittsburgh Medical Center, Pittsburgh

Medical University of South Carolina, Charleston

University of Texas Southwestern, Dallas

Baylor College of Medicine, Pulmonary & Critical Care, Houston

University of Texas Health Science Center at San Antonio, San Antonio

Inova Fairfax Hospital, Falls Church

University of Washington Medical Center, Seattle

Heart Care Associates, Milwaukee

Universitaet Wien, Vienna

Hospital Erasme, Brussels

University Hospital Gasthuisberg, Leuven

Peter Lougheed Centre, Calgary

London Health Science Centre, London

SMBD Jewish General Hospital, Montreal

Beijing Shijitan Hospital, Beijing

Peking Union Medical College Hospital, Beijing

Shanghai Pulmonary Hospital, Shanghai

Hospital Antoine Beclere, Clamart

PRIME Hospitals, Hyderbad

Care Institute of Medical Science, Ahmedabad

Lifecare Institute of Medical Sciences & Research, Ahmedabad

Narayana Hrudayalaya Institute of Medical Sciences, Bangalore

Asian Heart Institute and Research Centre, Parel Mumbai

Poona Hospital and Research Centre, Pune

Sri Ramachandra Medical College, Chennai

G. Kuppuswamy Naidu Memorial Hospital, Coimbatore

K. S. Hospital, Chennai, Tamil Nadu

Sir Ganga Ram Hospital, New Delhi

Ruby Hall Clinic, Pune

Care Hospital, Visakhapatnam, Andra Pradesh

Hadassah Ein-Kerem Medical Center, Jerusalem

Rabin Medical Center, Petah Tikva

Tel Hashomer Medical Center, Ramat Gan

Universita degli Studi Bologna, Bologna

Instituto Nacional de Cardiologia, Mexico City

Hospital Universitario UANL, Monterrey

Unidad de Investigacion Clinica en Medicina (UDICEM), Monterrey

VU Medisch Centrum (VUCM), Amsterdam

Krakowski Szpital Specjalistyczny im. (Kraków Specialist Hospital), Krakow

National Tuberculosis and Lung Disease Research Institute, Warsaw

Wojewódzki Szpital Specjalistyczny we Wroclawiu (Provincial Specialist Hospital in Wrocław), Wroclaw

Auxilio Mutuo Hospital, Guaynabo

Sponsors
All Listed Sponsors
lead

United Therapeutics

INDUSTRY